Quality/QA Solutions for Biotech
Assyro AI empowers quality assurance professionals in biotechnology companies with intelligent regulatory tools. Assyro AI helps quality assurance professionals maintain GxP compliance, track regulatory inspections, and ensure documentation integrity. Stay audit-ready and proactively address quality issues with AI-powered intelligence.
What Quality/QA Teams Do
- Ensuring GMP/GLP/GCP compliance across operations
- Managing quality systems and documentation
- Preparing for and responding to regulatory inspections
- Overseeing deviation management and CAPA processes
- Maintaining training and qualification records
Challenges in Biotech
- Managing increasing inspection scrutiny and expectations
- Tracking evolving GxP regulations and guidance
- Maintaining comprehensive audit trails and documentation
- A 5-person RA team is handling work that used to require a department of 15
- First IND prep takes 8-12 weeks because everything is manual and fragmented
How Assyro AI Helps
- Track GxP regulation changes and enforcement trends
- Monitor FDA warning letters and 483 observations
- Generate inspection-ready documentation
- Compress IND prep from 8-12 weeks to under 3 weeks with AI-assisted drafting and validation
- Coordinate CRO deliverables in one workspace with version control and traceable handoffs
Key Skills We Support
- GxP compliance
- Audit management
- CAPA processes
- Quality systems
- Documentation control
Regulations We Cover
- 21 CFR Part 600
- ICH Q5-Q12
- FDA CBER guidance
- EMA ATMPs
- Biosimilar guidance
Frequently Asked Questions
Assyro AI helps QA professionals track GxP regulations, monitor FDA enforcement actions, and maintain compliance documentation. Our AI alerts you to inspection trends and helps prepare responses to observations.
Regulatory Context
Quality/QA teams in Biotech depend on current regulatory intelligence to keep submissions, quality narratives, and inspection responses aligned with health-authority expectations.
Common Mistakes
- Only reviewing quality records during inspections instead of continuously.
- Missing trend analysis across recurring deviations and CAPAs.
- Separating compliance tracking from regulatory change monitoring.
Key Regulatory Terms
- Good Manufacturing Practice
GMP is the minimum standard for the methods, facilities, and controls used to manufacture a drug, enforced through adulteration: a drug made outside GMP is legally adulterated regardless of whether it passes its release tests.
- Corrective and Preventive Action
CAPA is the quality-system element that investigates a detected problem to root cause and eliminates that cause so it cannot recur, unlike a correction, which only fixes the affected batch.
- Deviation
Deviation is a departure from an approved instruction, procedure, specification, or established standard in a regulated process, which GMP requires to be recorded and justified, and investigated whenever it is critical or unexplained.
Relevant Regulatory Intelligence
Related Actions
Other Roles in Biotech
Quality/QA in Other Industries
Ready to Transform Your Quality/QA Operations?
See how Assyro AI can accelerate regulatory work for quality assurance professionals in biotechnology companies.
Schedule a Demo